Page 43 - Path Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Google Calls COVID Tracing App Security Flaw 'Hypothetical' By Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing. Sign up for our California newsletter You must correct or enter the following before you can sign up: Email (NOTE: Free email domains not supported) Primary area of interest Thank You! L...

UiPath Inc (NYSE: PATH) shares are up more than 20% since the company priced its April IPO at $56. UiPath automates repetitive workplace processes. The company reported $607.6 million in revenue in the last fiscal year, up 81% year-over-year. At the same time, UiPath’s net loss narrowed from... Read More...

15 Companies with the Best Benefits 15 Companies with the Best Benefits. Click to skip ahead and jump to the The vast majority of people are working as salaried individuals, which means that the majority of their income is derived from their salary, which of course means that these people are employed at different businesses. Research suggests that most people want to work in big corporations for a variety of reasons, which include better learning opportunities, better growth and of course, many try to choose companies with the best benefits. Nowadays, there are a lot of talented individuals...

Researchers from Boston University School of Medicine (BUSM) have developed a novel Artificial Intelligence (AI) tool to predict the grade of IFTA, a known structural correlate of progressive and chronic kidney disease.

New AI tool predicts the extent of chronic damage in the kidney Chronic kidney disease (CKD) is caused by diabetes and hypertension. In 2017, the global prevalence of CKD was 9.1 percent, which is approximately 700 million cases. Chronic kidney damage is assessed by scoring the amount of interstitial fibrosis and tubular atrophy (IFTA) in a renal biopsy sample. Although image digitization and morphometric (measuring external shapes and dimensions) techniques can better quantify the extent of histologic damage, a more widely applicable way to stratify kidney disease severity is needed. Now, re...